# Forevergen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forevergen

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.forevergen.cn
- Latest round: Series A (Apr 20, 2017)
- Investors on record: 1

## About

Established in 2010 and based in Guangzhou, China, Forevergen is a medical service provider that focuses on development of medical research and molecular diagnostic products, providing animal disease model construction platform and relevant platforms. The company covers an area of ??nearly 6,000 square meters, has more than 40 invention patents, and 8 Guangdong Province high-tech product certificates. It has been recognized as a National High-Tech Enterprise and a Guangzhou City Science and Technology Innovation Small Giant Enterprise. Guangzhou Yongnuo Medical Laboratory is a subsidiary of Forevergen.  In April 2017,the company closed a series A funding.

Forevergen provides molecular diagnostic products such as instruments, reagents and related consumables, as well as sequencing equipment and digital PCR and other equipment platforms. Specific products include MicroDrop digital PCR detection system, BCR-ABL fusion gene detection kit, EGFR gene mutation detection kit, KRAS gene mutation detection kit, etc. Forevergen also provides services such as tumor gene testing, genetic testing, pathogenic microbial testing, and personalized diagnosis of epilepsy gene testing.

The company generates revenue by provideing molecular diagnostic products and PCR technology services such as genetic testing.

## Funding rounds

- Series A, Apr 20, 2017 — Guangzhou Financial Innovation Investment Holdings

## Investors

- Guangzhou Financial Innovation Investment Holdings (https://capitalatlas.ai/funds/guangzhou-financial-innovation-investment-holdings) — Series A